Proton Therapy for Low and Intermediate Risk Prostate Cancer



Status:Active, not recruiting
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/29/2018
Start Date:April 2008
End Date:December 2033

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase II Study of Hypofractionated Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate

The purpose of this trial is to give a shorter course (5 ½ weeks) of radiation that has as
little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks)
of radiation, without decreasing the chance of killing prostate cancer cells.

Low Risk - Total of 70 Gy/CGE over 28 treatments

Intermediate Risk - Total of 72.5 Gy/CGE over 29 treatments

Inclusion Criteria

- Prostate cancer.

- Gleason score 2-7.

- PSA ≤ 20 ng/ml.

Exclusion Criteria:

- Previous prostate cancer surgery or pelvic radiation.

- Prior or current chemotherapy for prostate cancer.

- Active inflammatory bowel disease (Crohn's disease, diverticulitis or ulcerative
colitis) affecting the rectum.

- History of proximal urethral stricture requiring dilatation.

- History of hip replacement.

- Diabetes requiring medication.

- Prior intrapelvic surgery.

- Current and continuing anticoagulation with Warfarin sodium (Coumadin), Clopidogrel
bisulfate (Plavix), enoxaparin sodium (Lovenox), or aspirin/er dipyridamole
(Aggrenox).

- On Flomax (Tamsulosin), Hytrin (Terazosin) or Cardura (Doxazosin), Uroxatral
(alfuzosin HCl).

- Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use
during radiation.
We found this trial at
1
site
University of Florida Proton Therapy Institute
2015 Jefferson St
Jacksonville, Florida 32206
(904) 588-1800
University of Florida Proton Therapy Institute When the University of Florida Proton Therapy Institute opened...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials